Andrew L. Farkas serves as Executive at CHARTERMAC, where they oversee executive responsibilities. Since joining the company, Andrew L. Farkas has executed 16 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 10, 2020 involved purchasing 48,355 shares valued at $0.
Andrew L. Farkas currently holds 156,627 shares of CHARTERMAC (CHC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew L. Farkas has been a net neutral trader of CHC stock. They have purchased $0 and sold $0 worth of shares.
Andrew L. Farkas's most recent insider trade was on Mar 10, 2020, when they purchased 48,355 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 9, 2020 | XAN | $0 | Purchase | 3,607 | $N/A | Discretionary |
| Jan 21, 2020 | XAN | $0 | Award | 12,668 | $N/A | Discretionary |
| Jan 22, 2019 | XAN | $0 | Award | 14,734 | $N/A | Discretionary |
| Jan 31, 2018 | RSO | $531.9K | Other | 21,276 | $25.00 | Discretionary |
| Jan 18, 2018 | RSO | $0 | Award | 15,625 | $N/A | Discretionary |
| Jan 25, 2017 | RSO | $0 | Award | 30,048 | $N/A | Discretionary |
| Nov 18, 2016 | RSO | $0 | Purchase | 13,753 | $N/A | Discretionary |
| Nov 17, 2016 | RSO | $0 | Purchase | 21,444 | $N/A | Discretionary |
| Nov 16, 2016 | RSO | $0 | Purchase | 21,276 | $N/A | Discretionary |
| Oct 6, 2010 | CLNH.OB | $0 | Conversion | 0 | $N/A | Discretionary |
| Jun 15, 2007 | CHC | $23.5K | Award | 1,217 | $19.31 | Discretionary |
| Jan 3, 2007 | CHC | $34.0K | Award | 1,584 | $21.47 | Discretionary |
| Jun 30, 2006 | CHC | $34.0K | Award | 1,814 | $18.74 | Discretionary |
| Dec 30, 2005 | CHC | $25.0K | Award | 1,181 | $21.18 | Discretionary |